Hair loss breakthrough? new Under-the-Tongue pill tested in 142 men
NCT ID NCT06924632
First seen May 12, 2026 · Last updated Jun 20, 2026 · Updated 7 times
Summary
This study tested a new way to take minoxidil for male pattern baldness: a tablet placed under the tongue. 142 men with moderate to severe hair loss took either the minoxidil tablet or a placebo twice daily for 24 weeks. The goal was to see if this method increases hair count and is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALE PATTERN BALDNESS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
DIRECT
East Melbourne, Victoria, 3002, Australia
-
DIRECT
Pascoe Vale, Victoria, 3044, Australia
-
Premier Specialists Pty Ltd
Kogarah, New South Wales, 2217, Australia
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
minoxidil sublingual tablet
What this could lead to
If it works, this could offer a new, easy-to-take option for men with hair loss that may be more effective than current treatments.
What could go wrong
This is a completed Phase 3 trial with 142 men, but results are not yet published. The new sublingual form may not work better than existing minoxidil or could have side effects like dizziness or heart issues.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.